Lasheen DS - Search Results

1

A Fluorescence-Based Assay to Probe Inhibitory Effect of Fructose Mimics on GLUT5 Transport in Breast Cancer Cells.

Rana N, Aziz MA, Serya RAT, Lasheen DS, Samir N, Wuest F, Abouzid KAM, West FG. Rana N, et al. Among authors: lasheen ds. ACS Bio Med Chem Au. 2022 Nov 7;3(1):51-61. doi: 10.1021/acsbiomedchemau.2c00056. eCollection 2023 Feb 15. ACS Bio Med Chem Au. 2022. PMID: 37101605 Free PMC article.

2

Analogs design, synthesis and biological evaluation of peptidomimetics with potential anti-HCV activity.

Lasheen DS, Ismail MA, Abou El Ella DA, Ismail NS, Eid S, Vleck S, Glenn JS, Watts AG, Abouzid KA. Lasheen DS, et al. Bioorg Med Chem. 2013 May 15;21(10):2742-55. doi: 10.1016/j.bmc.2013.03.017. Epub 2013 Mar 24. Bioorg Med Chem. 2013. PMID: 23583031

3

Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents.

Aziz MA, Serya RA, Lasheen DS, Abdel-Aziz AK, Esmat A, Mansour AM, Singab AN, Abouzid KA. Aziz MA, et al. Among authors: lasheen ds. Sci Rep. 2016 Apr 15;6:24460. doi: 10.1038/srep24460. Sci Rep. 2016. PMID: 27080011 Free PMC article.

4

Covalent EGFR Inhibitors: Binding Mechanisms, Synthetic Approaches, and Clinical Profiles.

Hossam M, Lasheen DS, Abouzid KA. Hossam M, et al. Among authors: lasheen ds. Arch Pharm (Weinheim). 2016 Aug;349(8):573-93. doi: 10.1002/ardp.201600063. Epub 2016 Jun 3. Arch Pharm (Weinheim). 2016. PMID: 27258393 Review.

5

Toward discovery of mutant EGFR inhibitors; Design, synthesis and in vitro biological evaluation of potent 4-arylamino-6-ureido and thioureido-quinazoline derivatives.

Mowafy S, Galanis A, Doctor ZM, Paranal RM, Lasheen DS, Farag NA, Jänne PA, Abouzid KA. Mowafy S, et al. Among authors: lasheen ds. Bioorg Med Chem. 2016 Aug 15;24(16):3501-12. doi: 10.1016/j.bmc.2016.05.063. Epub 2016 May 30. Bioorg Med Chem. 2016. PMID: 27288180

6

Design and Synthesis of 4-Anilinothieno[2,3-d]pyrimidine-Based Compounds as Dual EGFR/HER-2 Inhibitors.

Abd El Hadi SR, Lasheen DS, Hassan MA, Abouzid KA. Abd El Hadi SR, et al. Among authors: lasheen ds. Arch Pharm (Weinheim). 2016 Nov;349(11):827-847. doi: 10.1002/ardp.201600197. Epub 2016 Oct 13. Arch Pharm (Weinheim). 2016. PMID: 27734525

7

Click and Release: SO₂ Prodrugs with Tunable Release Rates.

Ji X, El-Labbad EM, Ji K, Lasheen DS, Serya RA, Abouzid KA, Wang B. Ji X, et al. Among authors: lasheen ds. Org Lett. 2017 Feb 17;19(4):818-821. doi: 10.1021/acs.orglett.6b03805. Epub 2017 Jan 30. Org Lett. 2017. PMID: 28133965

8

Synthesis, ADMET Properties, and Biological Evaluation of Benzothiazole Compounds Targeting Chemokine Receptor 2 (CXCR2).

Mehanna WE, Lu T, Debnath B, Lasheen DS, Serya RAT, Abouzid KA, Neamati N. Mehanna WE, et al. Among authors: lasheen ds. ChemMedChem. 2017 Jul 6;12(13):1045-1054. doi: 10.1002/cmdc.201700229. Epub 2017 Jun 14. ChemMedChem. 2017. PMID: 28544630

9

How to train your inhibitor: Design strategies to overcome resistance to Epidermal Growth Factor Receptor inhibitors.

Milik SN, Lasheen DS, Serya RAT, Abouzid KAM. Milik SN, et al. Among authors: lasheen ds. Eur J Med Chem. 2017 Dec 15;142:131-151. doi: 10.1016/j.ejmech.2017.07.023. Epub 2017 Jul 18. Eur J Med Chem. 2017. PMID: 28754471 Free article. Review.

10

Discovery of anilino-furo[2,3-d]pyrimidine derivatives as dual inhibitors of EGFR/HER2 tyrosine kinase and their anticancer activity.

Hossam M, Lasheen DS, Ismail NSM, Esmat A, Mansour AM, Singab ANB, Abouzid KAM. Hossam M, et al. Among authors: lasheen ds. Eur J Med Chem. 2018 Jan 20;144:330-348. doi: 10.1016/j.ejmech.2017.12.022. Epub 2017 Dec 9. Eur J Med Chem. 2018. PMID: 29275232

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters